Syncom Formulations is trading at ₹23.36, up 5.23%, with no confirmed company-specific catalyst identified for the September 29 move.
- The September 28 rally was described as occurring amid exceptional volume and technical momentum; reported volume was 6.05 crore shares.
- Promoter dividend waivers were reported on September 26, but coverage did not connect them to the share-price move.